Daily news and information for physicians in a range of specialties and practice settings.
“We are constantly looking for new molecules with which to treat COPD patients.”
"The frequency of causing tardive dyskinesia is lesser, but it’s not zero."
In 2013, it was estimated that because of biosimilars, the US could save $250 billion throughout the next 10 years.
Dupixent, combined with topical corticosteroids significantly improved measures such as disease severity, skin clearing, itching, and overall quality of life in patients.
According to the FDA, Ocaliva has been identified in 19 cases of death and 11 cases of serious liver damage, and has been excessively dosed in some adult patients with moderate to severe decreases in liver function.
The response letter indicated the need for additional clinical data in order to further evaluate sirukumab's safety profile.
Actemra/RoActemra has potential to change how GCA is treated.
The sc2Wear Infusor allows the opportunity to deliver furosemide subcutaneously and at home, to keep HF patients in need of diuresis out of the hospital.
Researchers found two loci, TRPM1 and ABHD2/RLBP1, with previously unrecognized associations related to the risk of age-related macular degeneration.
The researchers noted that the majority of research has focused on hormonal differences, despite significant differences in immune function between the sexes.
Copyright© MD Magazine 2006-2017 Intellisphere, LLC. All Rights Reserved.